NATCOPHARM Intraday Analysis...

NATCOPHARM Share Price

Open 772.50 Change Price %
High 783.50 1 Day 11.55 1.51
Low 770.00 1 Week -17.95 -2.25
Close 778.15 1 Month -241.35 -23.67
Volume 341187 1 Year -32.10 -3.96
52 Week High 1090.00
52 Week Low 671.10
NATCOPHARM Important Levels
Resistance 2 790.66
Resistance 1 785.51
Pivot 777.22
Support 1 770.79
Support 2 765.64
NSE INDIA Most Active Stocks
JPASSOCIAT 19.15 17.13%
FORTIS 159.95 9.33%
GMRINFRA 18.75 6.84%
PNB 113.45 -1.00%
SUZLON 13.00 3.59%
RCOM 27.60 0.91%
SUNPHARMA 569.65 5.21%
IDBI 77.15 4.12%
UNITECH 7.15 3.62%
TATASTEEL 677.75 6.31%
More..
NSE INDIA Top Gainers Stocks
VISESHINFO 0.25 25.00%
DYNAMATECH 1947.65 20.00%
ARCHIES 40.50 20.00%
CNOVAPETRO 36.65 19.97%
JPASSOCIAT 19.15 17.13%
CUPID 301.90 13.41%
ZYLOG 3.95 11.27%
TCIFINANCE 31.15 11.25%
FCSSOFT 0.50 11.11%
VSSL 167.15 10.84%
More..
NSE INDIA Top Losers Stocks
MVL 0.40 -11.11%
MVL 0.40 -11.11%
JUBILANT 883.80 -10.89%
AGRITECH 149.80 -5.49%
ADHUNIKIND 68.40 -5.00%
AGARIND 362.25 -5.00%
ANTGRAPHIC 0.95 -5.00%
GITANJALI 24.75 -4.99%
VAKRANGEE 189.70 -4.98%
NAGREEKCAP 45.05 -4.96%
More..

Natco Pharma Limited (NSE: NATCOPHARM)

NATCOPHARM Technical Analysis 4
As on 23rd Feb 2018 NATCOPHARM Share Price closed @ 778.15 and we RECOMMEND Sell for LONG-TERM with Stoploss of 911.65 & Strong Sell for SHORT-TERM with Stoploss of 941.08 we also expect STOCK to react on Following IMPORTANT LEVELS.
NATCOPHARM Target for February
1st Target up-side 1011.73
2nd Target up-side 1057.17
3rd Target up-side 1102.61
1st Target down-side 882.07
2nd Target down-side 836.63
3rd Target down-side 791.19
NATCOPHARM Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is Below 30 Over Sold
MFI (14) MFI is Below 20 Over Sold
CCI (20) CCI is -83.57 Sideways
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Short Sell 843.40
10 Day Avg Volume Traded -26.16 % Less then 10 Day Average Volume
NATCOPHARM Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
NATCOPHARM Address
NATCOPHARM
N/A
NATCOPHARM Latest News
Natco Pharma - Natco receives Generic Sofosbuvir (Sovaldi) approval for India   Moneycontrol.com   - 12th Mar 15
NATCO Pharma stock rises most on US court ruling   Business Today   - 11th Mar 15
Buy Natco Pharma; target of Rs 1920: ICICIdirect   Moneycontrol.com   - 11th Mar 15
UPDATE 1-India's Natco Pharma ties up with Gilead on hepatitis C drugs   Reuters   - 02nd Mar 15
Natco Pharma - Q3 results on Feb 11, 2015   Moneycontrol.com   - 30th Jan 15
Natco Pharma dips on preferential share allotment at discount   Business Standard   - 17th Dec 14
Natco Pharma CFO passes away   Hindu Business Line   - 23rd Oct 14
Gilead Sciences, Inc. v. Natco Pharma Ltd. (Fed. Cir.)   JD Supra (press release)   - 25th Jul 14
Gilead Sciences, Inc. v. Natco Pharma Limited   Lexology (registration)   - 08th May 14
Gilead Sciences, Inc. v. Natco Pharma Ltd. (Fed. Cir. 2014)   Patent Docs   - 29th Apr 14
Interactive Technical Analysis Chart Natco Pharma Limited ( NATCOPHARM NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Natco Pharma Limited
NATCOPHARM Business Profile
Natco Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 2,439.26 crore.The company has reported a consolidated sales of Rs 179.22 crore and a Net Profit of Rs 24.26 crore for the quarter ended Sep 2013.The company management includes V C Nannapaneni - Chairman & Managing Director, Rajeev Nannapaneni - Vice Chairman & CEO, T V Rao - Nominee Director, G S Murthy - Director, B S Bajaj - Director, P Bhaskara Narayana - Director & CFO, A K S Bhujanga Rao - President & Director, Nitin Jagannath Deshmukh - Director. It is listed on the BSE with a BSE Code of 524816 and the NSE with an NSE Code of NATCOPHARM.Its Registered office is at NATCO House, Road No.2,,Banjara Hills Hyderabad,Andhra Pradesh - 500034.Their Registrars are Venture Capital & Corporate Investments Pvt. Ltd.